A detailed history of Gateway Investment Advisers LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 587,717 shares of MRK stock, worth $57.3 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
587,717
Previous 584,709 0.51%
Holding current value
$57.3 Million
Previous $72.4 Million 7.8%
% of portfolio
0.74%
Previous 0.82%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$111.15 - $128.97 $334,339 - $387,941
3,008 Added 0.51%
587,717 $66.7 Million
Q2 2024

Jul 12, 2024

SELL
$123.8 - $132.96 $184,462 - $198,110
-1,490 Reduced 0.25%
584,709 $72.4 Million
Q1 2024

Apr 12, 2024

SELL
$113.24 - $131.95 $4.27 Million - $4.98 Million
-37,739 Reduced 6.05%
586,199 $77.3 Million
Q4 2023

Jan 09, 2024

SELL
$100.18 - $109.02 $74,634 - $81,219
-745 Reduced 0.12%
623,938 $68 Million
Q3 2023

Oct 19, 2023

SELL
$102.95 - $114.33 $6.94 Million - $7.71 Million
-67,425 Reduced 9.74%
624,683 $64.3 Million
Q2 2023

Jul 13, 2023

SELL
$108.61 - $118.38 $1.33 Million - $1.45 Million
-12,251 Reduced 1.74%
692,108 $79.9 Million
Q1 2023

Apr 11, 2023

SELL
$102.94 - $114.86 $6.46 Million - $7.21 Million
-62,738 Reduced 8.18%
704,359 $74.9 Million
Q4 2022

Jan 13, 2023

BUY
$87.44 - $112.11 $490,450 - $628,824
5,609 Added 0.74%
767,097 $0
Q3 2022

Oct 07, 2022

SELL
$84.53 - $94.96 $572,859 - $643,543
-6,777 Reduced 0.88%
761,488 $65.6 Million
Q2 2022

Jul 13, 2022

BUY
$83.49 - $94.64 $212,148 - $240,480
2,541 Added 0.33%
768,265 $70 Million
Q1 2022

Apr 14, 2022

BUY
$73.51 - $82.4 $435,179 - $487,808
5,920 Added 0.78%
765,724 $62.8 Million
Q4 2021

Jan 14, 2022

SELL
$72.28 - $90.54 $1.61 Million - $2.02 Million
-22,287 Reduced 2.85%
759,804 $58.2 Million
Q3 2021

Oct 22, 2021

BUY
$71.68 - $78.83 $102,072 - $112,253
1,424 Added 0.18%
782,091 $58.7 Million
Q2 2021

Jul 13, 2021

SELL
$70.31 - $77.77 $125,995 - $139,363
-1,792 Reduced 0.23%
780,667 $60.7 Million
Q1 2021

Apr 14, 2021

SELL
$68.86 - $81.11 $364,062 - $428,828
-5,287 Reduced 0.67%
782,459 $60.3 Million
Q4 2020

Jan 14, 2021

SELL
$71.77 - $79.65 $13 Million - $14.4 Million
-181,336 Reduced 18.71%
787,746 $64.4 Million
Q3 2020

Oct 19, 2020

SELL
$73.18 - $82.95 $3.51 Million - $3.98 Million
-48,018 Reduced 4.72%
969,082 $80.4 Million
Q2 2020

Jul 15, 2020

SELL
$70.42 - $80.13 $7.79 Million - $8.86 Million
-110,576 Reduced 9.81%
1,017,100 $78.7 Million
Q1 2020

Apr 13, 2020

SELL
$63.36 - $87.82 $6.08 Million - $8.43 Million
-95,989 Reduced 7.84%
1,127,676 $86.8 Million
Q4 2019

Jan 09, 2020

SELL
$77.58 - $87.54 $1.03 Million - $1.17 Million
-13,339 Reduced 1.08%
1,223,665 $111 Million
Q3 2019

Oct 15, 2019

SELL
$76.08 - $82.93 $5.59 Million - $6.09 Million
-73,475 Reduced 5.61%
1,237,004 $104 Million
Q2 2019

Jul 17, 2019

SELL
$69.84 - $81.59 $4.21 Million - $4.91 Million
-60,236 Reduced 4.39%
1,310,479 $110 Million
Q1 2019

Apr 10, 2019

SELL
$69.58 - $79.36 $795,786 - $907,640
-11,437 Reduced 0.83%
1,370,715 $114 Million
Q4 2018

Jan 14, 2019

BUY
$65.24 - $75.71 $379,696 - $440,632
5,820 Added 0.42%
1,382,152 $106 Million
Q3 2018

Oct 16, 2018

SELL
$57.69 - $67.84 $917,386 - $1.08 Million
-15,902 Reduced 1.14%
1,376,332 $97.6 Million
Q2 2018

Jul 11, 2018

SELL
$50.83 - $59.72 $1.53 Million - $1.8 Million
-30,133 Reduced 2.12%
1,392,234 $84.5 Million
Q1 2018

Apr 12, 2018

SELL
$50.96 - $59.23 $3.36 Million - $3.9 Million
-65,896 Reduced 4.43%
1,422,367 $77.5 Million
Q4 2017

Jan 17, 2018

SELL
$51.62 - $61.64 $1.74 Million - $2.08 Million
-33,762 Reduced 2.22%
1,488,263 $83.7 Million
Q3 2017

Oct 16, 2017

BUY
$58.67 - $63.13 $89.3 Million - $96.1 Million
1,522,025
1,522,025 $97.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.